CNBX Pharmaceuticals Inc. (CNBX)

CNBX Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is September - August.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug 31, 2025	Aug 31, 2024	Aug 31, 2023	Aug 31, 2022	Aug 31, 2021
Cash & Equivalents	0.02	0.03	0.13	0.12	1.39
Cash & Short-Term Investments	0.02	0.03	0.13	0.12	1.39
Cash Growth	-42.80%	-79.63%	10.37%	-91.52%	78.30%
Prepaid Expenses	0	0	0.09	0.08	0.2
Total Current Assets	0.02	0.03	0.22	0.2	1.59
Property, Plant & Equipment	-	-	0.27	0.44	0.64
Long-Term Investments	-	-	-	0.18	0.85
Total Assets	0.02	0.03	0.5	0.81	3.08
Accounts Payable	0.05	0.04	0.34	0.46	0.18
Accrued Expenses	1.04	0.93	0.61	-	-
Short-Term Debt	1.2	1.3	1.34	1.76	0.87
Other Current Liabilities	0.22	0.24	0.22	0.22	0.22
Total Current Liabilities	2.51	2.51	2.52	2.44	1.27
Other Long-Term Liabilities	-	-	-	0	-
Total Liabilities	2.51	2.51	2.52	2.44	1.27
Common Stock	0.06	0	0	0	0.01
Additional Paid-In Capital	22.72	22.47	22.24	18.03	17.06
Retained Earnings	-25.27	-24.95	-24.26	-20.55	-16.83
Comprehensive Income & Other	-	-	-	0.88	1.55
Shareholders' Equity	-2.5	-2.48	-2.02	-1.63	1.81
Total Liabilities & Equity	0.02	0.03	0.5	0.81	3.08
Total Debt	1.2	1.3	1.34	1.76	0.87
Net Cash (Debt)	-1.18	-1.27	-1.21	-1.64	0.51
Net Cash Growth	-	-	-	-	-33.83%
Net Cash Per Share	-0.01	-0.04	-0.14	-1.34	0.45
Filing Date Shares Outstanding	753.2	31.11	28.31	1.26	1.24
Total Common Shares Outstanding	553.96	31.11	22.61	1.26	1.24
Working Capital	-2.5	-2.48	-2.29	-2.25	0.32
Book Value Per Share	-0.00	-0.08	-0.09	-1.30	1.46
Tangible Book Value	-2.5	-2.48	-2.02	-1.63	1.81
Tangible Book Value Per Share	-0.00	-0.08	-0.09	-1.30	1.46

Updated Aug 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.